Priority order of neonatal colonization by a probiotic or pathogenic Escherichia coli strain dictates the host

Tomas Hudcovic1, Petra Petr Hermanova1, Hana Kozakova1

  • 1Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Nový Hrádek, Czechia.

PubMed

Insights

Early colonization with probiotic Escherichia coli Nissle 1917 protects against pathogenic E. coli O6:K13:H1-induced colitis. Sequential colonization, not single dose, establishes protective anti-inflammatory effects in the gut microbiome.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Inflammatory bowel disease (IBD) in children is linked to microbiome imbalances.
  • Pathogenic Escherichia coli (E. coli) strains may worsen IBD.
  • Identifying bacteria that drive inflammation is crucial.

Purpose of the Study:

  • Compare immunomodulatory effects of probiotic E. coli Nissle 1917 and pathogenic E. coli O6:K13:H1.
  • Investigate bacterial adherence and invasion of epithelial cells.
  • Assess the impact of colonization sequence on immune response and colitis development.

Main Methods:

  • In vitro studies using Caco-2 cells and mouse bone marrow-derived dendritic cells (BM-DCs).
  • Gnotobiotic mouse models for in vivo colonization and experimental colitis induction (DSS).
  • Comparison of early vs. single-dose administration of E. coli Nissle 1917.

Main Results:

  • E. coli Nissle 1917 modulated Th1 immune response in vitro.
  • Neonatal colonization with E. coli Nissle 1917 established high intestinal levels and protected against E. coli O6:K13:H1-induced colitis.
  • Single-dose E. coli Nissle 1917 was ineffective in preventing colitis.
  • Early colonization by E. coli Nissle 1917 showed beneficial competitive interaction with E. coli O6:K13:H1.

Conclusions:

  • The sequence of bacterial colonization significantly influences gut immune response.
  • Early colonization with probiotic E. coli Nissle 1917 confers protection against pathogenic E. coli-driven colitis.
  • Beneficial competitive interactions between colonizing bacteria suggest anti-inflammatory potential.

Related Concept Videos

Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...